尿素分数排泄:肝硬化急性肾损伤鉴别诊断的简易工具
本研究在50例肝硬化腹水合并急性肾损伤(AKI)患者中回顾性分析尿素分数排泄(FEUrea)的鉴别诊断价值,并在独立50例队列中验证。推导队列中FEUrea鉴别急性肾小管坏死(ATN)与非ATN的曲线下面积为0.96,鉴别肝肾综合征(HRS)与非HRS为0.87,鉴别肾前性氮质血症(PRA)与HRS为0.81。结论认为FEUrea是肝硬化AKI鉴别诊断有前景的工具。
要点
- 推导队列FEUrea中位数:PRA 30.1 vs HRS 20.2 vs ATN 43.6,P<0.001。
- 验证队列FEUrea中位数:PRA 23.1 vs HRS 13.3 vs ATN 44.7,P<0.001。
- ATN与非ATN鉴别:推导队列曲线下面积0.96(切点33.4,敏感度85/特异度100),验证队列敏感度93/特异度97。
核心结论
- FEUrea是肝硬化患者急性肾损伤鉴别诊断有前景的工具。
研究设计与样本
- 回顾性分析纳入50例肝硬化腹水合并AKI患者作为推导队列,以裁定病因评估为参考标准。
- 在独立50例队列中进行验证,并进行bootstrap分析。
主要发现
- 推导队列AKI病因:PRA 21例、HRS 18例、ATN 11例;验证队列:PRA 21例、HRS 15例、ATN 14例。
- 推导队列FEUrea中位数:PRA 30.1 vs HRS 20.2 vs ATN 43.6,P<0.001。
- 验证队列FEUrea中位数:PRA 23.1 vs HRS 13.3 vs ATN 44.7,P<0.001。
- 推导队列曲线下面积(切点,敏感度/特异度):ATN vs 非ATN 0.96(33.4,85/100);HRS vs 非HRS 0.87(28.7,75/83);PRA vs HRS 0.81(21.6,90/61)。
- 验证队列敏感度/特异度:ATN vs 非ATN 93/97;HRS vs 非HRS 100/63;PRA vs HRS 67/80。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Current approaches to determine the cause of acute kidney injury (AKI) in patients with cirrhosis are suboptimal. The aim of this study was to determine the utility of fractional excretion of urea (FEUrea) for the differential diagnosis of AKI in patients with cirrhosis. A retrospective analysis was performed in patients (n = 50) with cirrhosis and ascites admitted with AKI. Using adjudicated etiology assessment as the reference standard, receiver operating curves and optimal cutoff, sensitivity (Sn), and specificity (Sp) for the diagnosis of prerenal azotemia (PRA), type 1 hepatorenal syndrome (HRS), and acute tubular necrosis (ATN) were derived. Validation was performed in an independent cohort (n = 50) and by bootstrap analysis. The causes of AKI (derivation:validation cohorts) were: PRA 21:21, HRS 18:15, and ATN 11:14. Median FEUrea was statistically different across all etiologies of AKI in the derivation cohort (PRA 30.1 vs. HRS 20.2 vs. ATN 43.6; P < 0.001) and validation cohort (PRA 23.1 vs. HRS 13.3 vs. ATN 44.7; P < 0.001). The area underneath the curve (cutoff, Sn/Sp) for FEUrea was 0.96 (33.4, 85/100) for ATN versus non-ATN, 0.87 (28.7, 75/83) for HRS versus non-HRS, and 0.81 (21.6, 90/61) for PRA versus HRS. When applied to the validation cohort, Sn/Sp were maintained for ATN versus non-ATN (93/97), HRS versus non-HRS (100/63), and for PRA versus HRS (67/80). After bootstrapping, Sn/Sp for FEUrea in the ATN versus non-ATN, HRS versus non-HRS, and PRA versus HRS was 88/96, 63/97, and 55/87, respectively. CONCLUSION: FEUrea is a promising tool for the differential diagnosis of AKI in patients with cirrhosis. (Hepatology 2018;68:224-233).
引用
- Patidar KR, Kang L, Bajaj JS, et al. Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology. 2018. PMID: 29315697. doi:10.1002/hep.29772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。